Genmab, Johnson and Johnson’s Trial of Darzalex in Solid Tumors is Cancelled

According to a story from Reuters, the Danish biotech company Genmab saw its share value drop by a quarter after Johnson & Johnson, which had partnered with the company to…

Continue Reading Genmab, Johnson and Johnson’s Trial of Darzalex in Solid Tumors is Cancelled
Studies Show Immunotherapy is an Effective Treatment for Multiple Myeloma
Source: Pixabay

Studies Show Immunotherapy is an Effective Treatment for Multiple Myeloma

Information in a Specialty Pharmacy Times report indicates that immunotherapy combined with chemotherapy may be an effective option for patients with drug-resistant multiple myeloma who have relapsed. Multiple myeloma is…

Continue Reading Studies Show Immunotherapy is an Effective Treatment for Multiple Myeloma
Kraft Foundation Funds Harvard Business School For Better Cancer Treatment Development Strategies
Source: Pixabay

Kraft Foundation Funds Harvard Business School For Better Cancer Treatment Development Strategies

The Myra and Robert Kraft Family Foundation was established in 2016 creating an initiative to to bring together an alliance between the Harvard Business School with the Broad Institute of…

Continue Reading Kraft Foundation Funds Harvard Business School For Better Cancer Treatment Development Strategies
These Rare Disease Treatments Just Became a Lot More Affordable for Australians
source: pixabay.com

These Rare Disease Treatments Just Became a Lot More Affordable for Australians

The Australian government has announced that almost that new treatments worth $300 million are being added to the Pharmaceutical Benefits Scheme. This program provides subsidized medical treatments to citizens of…

Continue Reading These Rare Disease Treatments Just Became a Lot More Affordable for Australians
A Popular Treatment For Multiple Myeloma May Have Deadly Side Effects
source: pixabay.com

A Popular Treatment For Multiple Myeloma May Have Deadly Side Effects

According to an article from deccanchronicle.com, a common treatment for cancer, called carfilzomib, may increase the risk of hypertension, heart failure, and heart attacks in patients with multiple myeloma. Multiple…

Continue Reading A Popular Treatment For Multiple Myeloma May Have Deadly Side Effects
A Pattern in Multiple Myeloma Research May Cause Lower African American Patient Survival Rates
Source: Pixabay

A Pattern in Multiple Myeloma Research May Cause Lower African American Patient Survival Rates

African Americans face a far higher danger of developing multiple myeloma-- especially African American men, who run three times the risk of a diagnosis. These groups are also about half…

Continue Reading A Pattern in Multiple Myeloma Research May Cause Lower African American Patient Survival Rates

The Search for the Right Multiple Myeloma Treatments in the Right Patients at the Right Times

Everybody responds to treatments differently. The drug, diet, or surgery that successfully helps one person, may have a neutral or even negative effect on another. This is why the medical…

Continue Reading The Search for the Right Multiple Myeloma Treatments in the Right Patients at the Right Times
Close Menu